Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma

Tumor Biology

Volumn 34, Issue 3, 2013, Pages 1729-1736

  Zhang, Wendong ^a   Dou, Huiqin ^a   Lam, Chileong ^b   Liu, Jixi ^c   Zhou, Jianfeng ^d   Liu, Yunsheng ^a   Wang, Xiuwen ^a  

^a SHANDONG UNIVERSITY   (China)

^b Macau Special Administrative Region   (Macao)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Adjuvant chemotherapy; Concurrent chemoradiotherapy; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION; LEUKOPENIA; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NAUSEA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; STOMATITIS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

EID: 84878707856     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0710-6     Document Type: Article

References (30)

1. Chen WQ, Zheng RS, Zhang SW, et al. Report of incidence and mortality in china cancer registries, 2008. Chin J Cancer Res. 2012;24(3):171-80.
2. Kutcher GJ, Fuks Z, Brenner H, et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 1991;21:169-82.
3. Al-Saraf M, LeBlanc M, Giri PG, et al. Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup Study 0099. J Clin Oncol. 1998;16:1310-7.
4. Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys. 1997;37:985-96.
5. Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2005;97:536-9.
6. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003;21:631-7.
7. Zhang L, Zhao C, Peng PJ, et al. Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results. J Clin Oncol. 2005;23:8461-8.
8. Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64:47-56.
9. Langendijk JA, Leemans CR, Buter J, et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol. 2004;22:4604-12.
10. Liu A, Swisher-McClure S, Millar LB, et al. Proton therapy for head and neck cancer: current applications and future directions. Transl Cancer Res. 2012;1:255-63.
11. Giap H, Giap B. Historical perspective and evolution of charged particle beam therapy. Transl Cancer Res. 2012;1(3):127-36.
12. Kyong Hwa P, Jeong Sun K, Yong P, et al. Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea. Cancer Chemother Pharmacol. 2010;66:643-51.
13. Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2012;13(2):163-71. Epub 2011 Dec 7.
14. Edge SB, Byrd DR, Compton CC, et al. AJCC (American Joint Committee on Cancer) cancer staging manual. 7th ed. New York: Springer; 2010. p. 41-56.
15. Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005.
16. Ma J, Mai HQ, Hong MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol. 2001;19(5):1350-7.
17. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207-14.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
19. Al-Kourainy K, Crissman J, Ensley J, et al. Excellent response to cis-platinum based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma. Am J Clin Oncol. 1988;11:553-7.
20. Bachouchi M, Cvitkovic E, Azli N, et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy. J Natl Cancer Inst. 1990;82:616-20.
21. Nakagawa K, Tsurutani J. Perspectives in drug development for cancer therapy in Asia. Chin Clin Oncol. 2012;1:17.
22. Dimery IW, Peters UI, Goepfert H, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol. 1993;11:1919-28.
23. Ai P, Tu L, Sun L, et al. Multiple annular lung metastases from a nasopharyngeal carcinoma. Quant Imaging Med Surg. 2012;2:291.
24. Kwong DL, Sham JS, Au GK, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol. 2004;22:2643-53.
25. Chen Y, Liu MZ, Liang SB, et al. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys. 2008;71:1356-66.
26. Zhang L, Zhao C, Ghimire Y, et al. The role of concurrent chemoradiation in the treatment of locally advanced nasopharyngeal carcinoma among endemic area: a meta-analysis of the phase III randomized trials. J Clin Oncol. 2008; 26:6032. (Available online at http://www.asco.org/ASCOv2/Meetings/Abstracts? &vmview=abst-detail-view&confID=55&abstracted =34253, accessed June 3, 2009).
27. David GP, Kei-Kian A, David MB, et al. NCCN clinical practice guidelines in oncology-Head and Neck Cancers, Version I, 2012, pp 30-32.
28. Wee J. Eng Huat Tan, Bee Choo Tai, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer Stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005;23:6730-8.
29. Chua DT, Sham JS, Kwong DL, et al. Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma[J]. Cancer. 2003;98(1):74-80.
30. Rassi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincritine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol. 1988;16:1401-10.